Lawsuit Over Atripla, Truvada Pay-to-Delay Generics Scheme Results in Defense Verdict for Gilead, Teva
This is the third antitrust trial victory for Gilead involving claims it participated in an Atripla and Truvada pay-to-delay generics scheme
This is the third antitrust trial victory for Gilead involving claims it participated in an Atripla and Truvada pay-to-delay generics scheme